RR

Rajnish Ranjan

Active Director Director DIN 06481777
DIN 06481777 First appointment Jan 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2013
Shareholding value •••• Premium profile

About Rajnish Ranjan

Data last updated:

Rajnish Ranjan is a Director at Allay Biotech Private Limited (since 2013). The company operates in Pharma. Allay Biotech Private Limited reported revenue of ₹18,481 (FY 2022).

DIN 06481777
Primary Designation Director
Industry Pharma
First Appointment 28 Jan 2013
Oldest Company Age 14 yrs
Largest company Allay Biotech Private Limited · ₹18,481 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Allay Biotech Private Limited U74999BR2012PTC018126
Director28 Jan 20132012₹18,481 (FY 2022)Active

Board colleagues of Rajnish Ranjan

NameDINCompanyDesignation
Amrita Kumari07112890Allay Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Allay Biotech Private Limited
Premium access

Shareholding and investment profile for Rajnish Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajnish Ranjan

Rajnish Ranjan currently holds 1 directorship: Allay Biotech Private Limited (Director, since 28 Jan 2013, revenue ₹18,481 (FY 2022)).

Rajnish Ranjan was first appointed on 28 Jan 2013 as Director at Allay Biotech Private Limited.

The current boards of Rajnish Ranjan's companies include Amrita Kumari (Allay Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available